Flukes (Liver, Lung, and Intestinal)

Published on 22/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1924 times

Chapter 293 Flukes (Liver, Lung, and Intestinal)

Several different trematodes, or flukes, can parasitize humans and cause disease. Flukes are endemic worldwide but are more prevalent in the less developed parts of the world. They include Schistosoma, or the blood flukes (Chapter 292), as well as fluke species that cause infection in the human biliary tree, lung tissue, and intestinal tract. These latter trematodes are characterized by complex life cycles. Sexual reproduction of adult worms in the definitive host produces eggs that are passed in the stool. Larvae, called miracidia, develop in freshwater. These, in turn, infect certain species of mollusks (snails or clams), in which asexual multiplication by parasite larvae produces cercariae. Cercariae then seek a 2nd intermediate host such as an insect, crustacean, or fish or attach to vegetation to produce infectious metacercariae. Humans acquire liver, lung, and intestinal fluke infections by eating uncooked, lightly cooked, pickled, or smoked foods containing these infectious parasite cysts. The “alternation of generations” requires that flukes parasitize more than 1 host (often 3) to complete their life cycle. Because parasitic flukes are dependent on these nonhuman species for transmission, the distribution of human fluke infection closely matches the ecologic range of the flukes.

Liver Flukes

Fascioliasis (Fasciola hepatica)

Fasciola hepatica, the sheep liver fluke, infects cattle, other ungulates, and occasionally humans. This infection affects ~17 million people worldwide and has been reported in many different parts of the world, particularly South America, Europe, Africa, China, Australia, and Cuba. Although F. hepatica is enzootic in North America, reported cases are extremely rare. Humans are infected by ingestion of metacercariae attached to vegetation, especially wild watercress, lettuce, and alfalfa. In the duodenum, the parasites excyst and penetrate the intestinal wall, liver capsule, and parenchyma. They wander for a few weeks before entering the bile ducts, where they mature. Adult F. hepatica (1-2.5 cm) commence oviposition approximately 12 wk after infection; the eggs are large (75-140 µm) and operculated. They pass to the intestines with bile and exit the body in the feces (see Fig. 292-1). On reaching freshwater, the eggs mature and hatch into miracidia, which infect specific snail intermediate hosts to multiply into many cercariae. These then emerge from infected snails and encyst on aquatic grasses and plants.

Clinical manifestations usually occur either during the liver migratory phase of the parasites or after their arrival at their final habitat in upper bile ducts. Fever, right upper quadrant pain, and hepatosplenomegaly characterize the 1st phase of illness. Peripheral blood eosinophilia is usually marked. As the worms enter bile ducts, most of the acute symptoms subside. On rare occasions, patients may suffer from obstructive jaundice or biliary cirrhosis, with signs of cholestasis, ascending cholangitis, cholelithiasis and jaundice with elevation in liver enzymes, direct bilirubin, and γ-glutamyl transpeptidase (GGT). F. hepatica infection is diagnosed by identifying the characteristic eggs in fecal smears or duodenal aspirates. Diagnosis can be suggested by positive serology and imaging that reveals acute hypodense liver lesions that change over time. Presentation can be dramatic in children, with features including generalized edema, hepatic cirrhosis with esophageal varices, and, in severe cases, death from generalized organ failure.

The recommended treatment of fascioliasis is triclabendazole (10 mg/kg once or twice PO) or bithionol (30-50 mg/kg once daily PO on alternate days for a total of 10-15 doses). In the USA, bithionol is available from the Centers for Disease Control and Prevention (telephone: 404-639-3670).

Clonorchiasis (Clonorchis sinensis)

Infection of bile passages with Clonorchis sinensis, the Chinese or oriental liver fluke, is endemic in China, other parts of East Asia, and Japan. Humans acquire infection by ingestion of raw or inadequately cooked freshwater fish carrying the encysted metacercariae of the parasite under their scales or skin. Metacercariae excyst in the duodenum and pass through the ampulla of Vater to the common bile duct and bile capillaries, where they mature into hermaphroditic adult worms (3-15 mm). C. sinensis worms deposit small operculated eggs (14-30 µm), which are discharged by way of the bile duct to the intestine and feces (see Fig. 292-1). The eggs mature and hatch outside the body, releasing motile miracidia into local freshwater streams, rivers, or ponds. If these are taken up by the appropriate snails, they develop into cercariae, which are in turn released from the snail to encyst under the skin or scales of freshwater fish.

Most individuals with C. sinensis infection, particularly those with few organisms, are minimally symptomatic. In heavily infected individuals, who tend to be older (>30 yr of age), localized obstruction of a bile duct results from repeated local trauma and inflammation. In these cases, cholangitis and cholangiohepatitis may lead to liver enlargement and jaundice. In Hong Kong, Korea, and other parts of Asia, cholangiocarcinoma is associated with chronic C. sinensis infection.

Clonorchiasis is diagnosed by examination of feces or duodenal aspirates for the parasite eggs. The recommended treatment of clonorchiasis is praziquantel (75 mg/kg/day divided tid PO for 2 days). An alternative, used in adults, is albendazole (10 mg/kg once daily PO for 7 days).

Lung Flukes

Paragonimiasis (Paragonimus spp.)

Human infection by the lung fluke Paragonimus westermani, and less frequently other species of Paragonimus, occurs throughout the Far East, in localized areas of West Africa, and in several parts of Central and South America. The highest incidence of paragonimiasis occurs in older children and adolescents 11-15 yr of age. Although P. westermani is found in many carnivores, human cases are relatively rare and seem to be associated with specific dietary habits, such as eating raw freshwater crayfish or crabs. These crustaceans contain the infective metacercariae in their tissues. After ingestion, the metacercariae excyst in the duodenum, penetrate the intestinal wall, and migrate to their final habitat in the lungs. Adult worms (5-10 mm) encapsulate within the lung parenchyma and deposit brown operculated eggs (60-100 µm), which pass into the bronchioles and are expectorated by coughing (see Fig. 292-1). Ova can be detected in the sputum of infected individuals or in their feces. If eggs reach freshwater, they hatch and undergo asexual multiplication in specific snails. The cercariae encyst in the muscles and viscera of crayfish and freshwater crabs.

Most individuals infected with P. westermani harbor low or moderate worm loads and are minimally symptomatic. The clinical manifestations include cough, production of rust-colored sputum, and hemoptysis (mimicking tuberculosis), which is the principal manifestation and occurs in 98% of symptomatic children. There are no characteristic physical findings, but laboratory examination usually demonstrates marked eosinophilia. Chest x-rays often reveal small patchy infiltrates or radiolucencies in the middle lung fields; however, radiographs may appear normal in one fifth of infected individuals. In rare circumstances, lung abscess, pleural or pericardial effusion, or bronchiectasis may develop. Extrapulmonary localization of P. westermani in the brain, peritoneum, intestines, or pericardium may rarely occur. Cerebral paragonimiasis occurs primarily in heavily infected individuals living in highly endemic areas of the Far East. The clinical presentation resembles jacksonian epilepsy or the symptoms of cerebral tumors.

Definitive diagnosis of paragonimiasis is established by identification of eggs in fecal or sputum smears. The recommended treatment of paragonimiasis is praziquantel (75 mg/kg/day divided tid PO for 2 days). Triclabendazole can also be used (5 mg/kg PO daily for 3 days).